Amber Luong
Otolaryngology · Houston, TXNPI 1013948835
Payments from drug & device makers
Across 528 payments — averaging $1502.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$228K
- Stryker$173K
- Sanofi$168K
- GSK$43K
- Eli Lilly$30K
- Sanofi-aventis U.S. LLC$30K
- plus $122K from 22 others
Across 2 payments — averaging $478.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$500
- Sanofi US Services Inc.$457
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 42 | $228,376 |
| Stryker | 156 | $172,878 |
| Sanofi | 66 | $167,791 |
| GSK | 55 | $42,509 |
| Eli Lilly | 1 | $29,853 |
| Sanofi-aventis U.S. LLC | 36 | $29,656 |
| Medtronic(2 entities) | 38 | $21,227 |
| AstraZeneca | 12 | $19,051 |
| Neurent Medical Limited | 13 | $16,980 |
| Aerin Medical Inc. | 14 | $15,393 |
| Regeneron Healthcare Solutions, Inc. | 26 | $15,013 |
| Regeneron | 12 | $14,821 |
| Intersect ENT, Inc. | 15 | $5,679 |
| Acclarent, Inc | 4 | $3,946 |
| Genentech, Inc. | 6 | $3,836 |
| Acelrx Pharmaceuticals, Inc. | 1 | $2,250 |
| Roche Products Limited | 3 | $1,120 |
| Arrinex, Inc. | 1 | $1,118 |
| Integra Lifesciences Corporation | 9 | $795 |
| Insmed, Inc. | 6 | $325 |
| Tactile Systems Technology Inc | 2 | $142 |
| Spirair, Inc. | 1 | $121 |
| Optinose US, Inc. | 4 | $88 |
| 3-d Matrix, Inc. | 1 | $74 |
| Baxter Healthcare | 1 | $30 |
| Boston Scientific | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
How this compares
$793,137 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Houston
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Stephen LaiHouston$968K
- Masayoshi TakashimaHouston$644K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$336K
- William YaoHouston$280K
- Martin CitardiHouston$264K
- Michael KaplanHouston$202K
- Andrew HuangHouston$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.